Symrise Partners with HBC to Expand Marine-Based Health Ingredients Portfolio
• Symrise AG has formed a strategic partnership with Norwegian company HBC to expand its health category portfolio with clinically-proven marine ingredients derived from Atlantic salmon.
• HBC plans to triple its production capacity by upgrading its Berkak facility into a state-of-the-art enzymatic hydrolysis plant for sustainable marine protein processing.
• The partnership will leverage Symrise's global market presence to promote HBC's scientifically-validated products, which have demonstrated benefits in metabolic, immune, gut, and mobility health.
© Copyright 2025. All Rights Reserved by MedPath